Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01461005
Other study ID # Dynamic Stabilization System
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date September 2011
Est. completion date September 2016

Study information

Verified date February 2020
Source Paradigm Spine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the Post-Market Surveillance study is to evaluate safety.


Description:

Paradigm Spine Dynamic Stabilization System (DSS) study is a prospective, multi-center, literature controlled study.


Recruitment information / eligibility

Status Terminated
Enrollment 1
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender All
Age group 21 Years to 85 Years
Eligibility Inclusion Criteria:

- Patient is skeletally mature (21-85 years old).

- Patient has degenerative spondylolisthesis (Grade 1-3) with objective evidence of neurologic impairment, kyphosis, and/or failed previous fusion (pseudarthrosis) at index level.

- Capable and willing to comply with the requirements unique to the study, adhere to the post-operative treatment and management program, and return for required follow-up examinations.

- Surgeon has determined that DSS™ System is an appropriate treatment for the patient without regard to the study.

Exclusion Criteria:

- The need for interbody cages, allograft, or any other assistance during surgery. Device is only to be used with autograft per FDA approved indications.

- Any medical, mental or surgical condition precluding the potential benefit of spinal surgery or surgery in general.

- Acute or chronic systemic, spinal or localized infections.

- Active, severe systemic and metabolic diseases.

- Obesity defined as Body Mass Index > 35.

- Subject is pregnant or interested in becoming pregnant in the next 36 months.

- Dependency on pharmaceutical drugs, drug abuse, or alcoholism.

- Lack of patient cooperation.

- Foreign body sensitivity to the implant material.

- Degenerative scoliosis greater than 25 degrees.

- Grade 4 degenerative spondylolisthesis (>75% slip).

- Significant osteopenia A screening questionnaire for osteopenia, SCORE (Simple Calculated Osteoporosis Risk Estimation), will be used to screen patients who require a DEXA bone mineral density measurement. If DEXA is required*, exclusion will be defined as a DEXA bone density measured T score of = -1.0 (The World Health Organization definition of osteopenia).

- Soft tissue deficit not allowing wound closure.

- Congenital abnormalities, tumors or other conditions that would prevent secure component fixation that has the potential to decrease the useful life of the device.

- Inadequate pedicles or vertebral body geometry of the thoracic, lumbar and sacral vertebrae.

- Bony lumbar spinal stenosis not related to the primary degenerative spondylolisthesis indication.

- Pars defect.

- Clinically compromised vertebral bodies at affected level due to current or past trauma.

- Prisoner or ward of the state.

- Currently in litigation regarding a spinal condition.

- Known allergy to titanium, titanium alloys, CoCrMo, polyethylene or MR contrast agents.

- Is currently involved in a study of another investigational product for similar purpose.

Study Design


Intervention

Device:
Dynamic Stabilization System (DSS)
Dynamic Stabilization System

Locations

Country Name City State
United States University of California, Davis Medical Center Sacramento California

Sponsors (2)

Lead Sponsor Collaborator
Paradigm Spine Musculoskeletal Clinical Regulatory Advisers

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants Who Have an Incidence of Serious or Device Related Adverse Events Due to Device or Procedure. The safety endpoint is defined as the incidence of serious or device related adverse events attributable to the device or procedure. Reoperations, revisions or removals of the Dynamic Stabilization System (DSS) System implant will be evaluated. 6 months
Secondary Measurement of Lower Back Pain as Assessed by Visual Analog Scale Lower back pain as measured by the Visual Analog Scale (VAS) on the scale from 0 (no pain) to 100 (worst imaginable pain) 6 months
Secondary Measurement of Right Leg Pain as Assessed by Visual Analog Scale Right leg pain as measured by the Visual Analog Scale (VAS) on the scale from 0 (no pain) to 100 (worst imaginable pain) 6 months
Secondary Measurement of Left Leg Pain as Assessed by Visual Analog Scale Left leg pain as measured by the Visual Analog Scale (VAS) on the scale from 0 (no pain) to 100 (worst imaginable pain) 6 months
Secondary Number of Participants With Improved Health as Measured by the EuroQOL Health Related Qualify of Life- 5 Dimensions-3 Level (EQ-5D-3L) Health Questionnaire Compared to Baseline. The EQ-5D-3L is a standardized instrument used as a measure of health outcomes. It contains questions in 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and provides a simple descriptive profile and single index for health status preference. In addition, there is a Visual Analog Scale (VAS). The VAS is the participant's rating of their health on a scale of 0 "worst imaginable health state" to 100 "best imaginable health state". Pre-Op, 6 weeks, 6 months, 12 months, and 24 months
Secondary Assessment of Back Pain Using the Oswestry Low Back Pain Disability Index (ODI). ODI is a questionnaire that provides information on back and the affects on managing every day life by diving questions into 10 sections. The total possible score for each section is 0-5. The scores are then converted into percentages ranging from 0% (minimal disability) to 100% (maximum possible disability). 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT03883022 - Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery N/A
Active, not recruiting NCT04542577 - PMCF Study on the Safety and Performance of PROSPACE 3D / PROSPACE 3D OBLIQUE / TSPACE 3D
Recruiting NCT04477447 - PMCF Study on the Safety and Performance of CESPACE 3D
Completed NCT02558621 - New Robotic Assistance System for Spinal Fusion Surgery N/A
Completed NCT00405691 - Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis Phase 3
Completed NCT00205101 - Clinical Outcome Study of the Triad Allograft for Posterior Lumbar Fusion
Enrolling by invitation NCT04204135 - The Course of Hip Flexion Weakness Following LLIF or ALIF
Recruiting NCT05238740 - Comparison of Standalone Anterior Lumbar Interbody Fusion (ALIF) L5/S1 Performed With Either rhBMP-2 or ViviGen® N/A
Not yet recruiting NCT02805985 - Post-market Surveillance Study of FLXfit™ TLIF Interbody Fusion Device N/A
Completed NCT02931279 - PASS OCT® Post-market Clinical Follow-up
Completed NCT02966639 - Validation of Appropriateness Criteria for the Surgical Treatment of Lumbar Degenerative Spondylolisthesis
Active, not recruiting NCT02057744 - MIS ReFRESH: Robotic vs. Freehand Minimally Invasive Spinal Surgeries
Completed NCT01711203 - The Addition of a Pilates Program for Short-Term Improvements in Patients With Spondylolysis or Spondylolisthesis N/A
Completed NCT00549913 - Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF) Phase 1/Phase 2
Terminated NCT00254852 - Evaluation of Radiographic and Patient Outcomes Following Lumbar Spine Fusion Using Demineralized Bone Matrix (DBM) Mixed With Autograft N/A
Terminated NCT00095095 - Lumbar Interbody Fusion Using the Telamon® Peek™ Versus the Telamon® Hydrosorb™ Fusion Device Phase 4
Active, not recruiting NCT03956537 - PMCF Neo Pedicle Screw and Cage Systems
Recruiting NCT05182489 - Adaptix RCT Evaluating Adaptix™ Versus PEEK Cages N/A
Completed NCT02884440 - Transverse Abdominis Plane Block for Anterior Approach Spine Surgery Phase 2
Enrolling by invitation NCT02958241 - Supine vs. Upright Weight Bearing MRI in the Evaluation of Patients With Lumbar Spondylolisthesis N/A